SUN PHARMACEUTICAL INDUSTRIES LTD. - Board recommends Dividend with Revised Audited FY14 results
Download 
|
< Back |
| 13 Aug 2014 | |
| Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at their meeting held August 12, 2014 recorded approval of Scheme of Arrangement and Reconstruction between Sun Pharmaceutical Industries Ltd., and Sun Pharma Global FZE in the nature of demerger and transfer of the Specified Undertaking of Sun Pharma Global FZE to the Company with effect from the appointed date of May 01, 2013 as per the order of the Hon'ble High Court of Gujarat, at Ahmedabad at its hearing held on July 10, 2014 and accordingly after taking into effect of the above Scheme, approved the revised annual accounts for the year ended March 31, 2014.<br/><br/>The Board of Directors of the Company also recommended payment of dividend of Rs. 1.50 (Rupees One and Fifty paise) per equity share of Re.1/- each of the Company for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting of the Company.<br/> | |
| View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback